6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
11m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
44m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
44m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
44m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
44m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Nuvectis Pharma Inc (NASDAQ:NVCT) — investor relations, events, news, and company updates on 6ix.

Latest News

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting

Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights

Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC

Nuvectis Pharma to Host a Virtual Key Opinion Leader Meeting to Discuss the NXP900 Phase 1b Program in Advanced Solid Tumors, Including the Combination with Osimertinib in NSCLC

CORRECTION: Nuvectis Pharma, Inc. Reports Third Quarter 2025 Financial Results and Business Highlights

Financials

Revenue

$0

Market Cap

$200.28 M

EPS

-1.32

Community Chat

Ask AI